Induction of anovulatory sterility by neonatal treatment with 5β-dihydrotestosterone in female rats

Y. Arai, K. Yamanouchi, S. Mizukami, R. Yanai, K. Shibata, H. Nagasawa

    Research output: Contribution to journalArticle

    19 Citations (Scopus)

    Abstract

    Wistar female rats were injected with testosterone (T) or 5β-dihydrotestosterone (5β-DHT) for the first 5 days of life. Neonatal treatment with 1 mg of T resulted in anovulatory persistent oestrous syndrome in 100% of the animals. In the females injected with 1 mg of 5β-DHT, 74% of the treated rats became sterile at 120 days of age. In addition, 0.5 mg 5β-DHT was also effective in inducing anovulatory persistent oestrus; the incidence of sterility was 10 and 80% at 60 and 120 days of age, respectively. When daily dose of 5β-DHT was reduced to 0.1 mg, however, only 33% of the rats resulted in sterility. These results suggest that the free form of T and non-aromatizable androgen, 5β-DHt, can permanently suppress the development of female type of neuroendocrine regulation. The possible participation of the process other than the central aromatization in androgenization will be discussed.

    Original languageEnglish
    Pages (from-to)439-443
    Number of pages5
    JournalActa Endocrinologica
    Volume96
    Issue number4
    Publication statusPublished - 1981

    Fingerprint

    Dihydrotestosterone
    Infertility
    Virilism
    Estrus
    Therapeutics
    Androgens
    Testosterone
    Wistar Rats
    Incidence

    ASJC Scopus subject areas

    • Endocrinology

    Cite this

    Arai, Y., Yamanouchi, K., Mizukami, S., Yanai, R., Shibata, K., & Nagasawa, H. (1981). Induction of anovulatory sterility by neonatal treatment with 5β-dihydrotestosterone in female rats. Acta Endocrinologica, 96(4), 439-443.

    Induction of anovulatory sterility by neonatal treatment with 5β-dihydrotestosterone in female rats. / Arai, Y.; Yamanouchi, K.; Mizukami, S.; Yanai, R.; Shibata, K.; Nagasawa, H.

    In: Acta Endocrinologica, Vol. 96, No. 4, 1981, p. 439-443.

    Research output: Contribution to journalArticle

    Arai, Y, Yamanouchi, K, Mizukami, S, Yanai, R, Shibata, K & Nagasawa, H 1981, 'Induction of anovulatory sterility by neonatal treatment with 5β-dihydrotestosterone in female rats', Acta Endocrinologica, vol. 96, no. 4, pp. 439-443.
    Arai Y, Yamanouchi K, Mizukami S, Yanai R, Shibata K, Nagasawa H. Induction of anovulatory sterility by neonatal treatment with 5β-dihydrotestosterone in female rats. Acta Endocrinologica. 1981;96(4):439-443.
    Arai, Y. ; Yamanouchi, K. ; Mizukami, S. ; Yanai, R. ; Shibata, K. ; Nagasawa, H. / Induction of anovulatory sterility by neonatal treatment with 5β-dihydrotestosterone in female rats. In: Acta Endocrinologica. 1981 ; Vol. 96, No. 4. pp. 439-443.
    @article{203ba9fa747c430f85da4cece206e4e5,
    title = "Induction of anovulatory sterility by neonatal treatment with 5β-dihydrotestosterone in female rats",
    abstract = "Wistar female rats were injected with testosterone (T) or 5β-dihydrotestosterone (5β-DHT) for the first 5 days of life. Neonatal treatment with 1 mg of T resulted in anovulatory persistent oestrous syndrome in 100{\%} of the animals. In the females injected with 1 mg of 5β-DHT, 74{\%} of the treated rats became sterile at 120 days of age. In addition, 0.5 mg 5β-DHT was also effective in inducing anovulatory persistent oestrus; the incidence of sterility was 10 and 80{\%} at 60 and 120 days of age, respectively. When daily dose of 5β-DHT was reduced to 0.1 mg, however, only 33{\%} of the rats resulted in sterility. These results suggest that the free form of T and non-aromatizable androgen, 5β-DHt, can permanently suppress the development of female type of neuroendocrine regulation. The possible participation of the process other than the central aromatization in androgenization will be discussed.",
    author = "Y. Arai and K. Yamanouchi and S. Mizukami and R. Yanai and K. Shibata and H. Nagasawa",
    year = "1981",
    language = "English",
    volume = "96",
    pages = "439--443",
    journal = "European Journal of Endocrinology",
    issn = "0804-4643",
    publisher = "BioScientifica Ltd.",
    number = "4",

    }

    TY - JOUR

    T1 - Induction of anovulatory sterility by neonatal treatment with 5β-dihydrotestosterone in female rats

    AU - Arai, Y.

    AU - Yamanouchi, K.

    AU - Mizukami, S.

    AU - Yanai, R.

    AU - Shibata, K.

    AU - Nagasawa, H.

    PY - 1981

    Y1 - 1981

    N2 - Wistar female rats were injected with testosterone (T) or 5β-dihydrotestosterone (5β-DHT) for the first 5 days of life. Neonatal treatment with 1 mg of T resulted in anovulatory persistent oestrous syndrome in 100% of the animals. In the females injected with 1 mg of 5β-DHT, 74% of the treated rats became sterile at 120 days of age. In addition, 0.5 mg 5β-DHT was also effective in inducing anovulatory persistent oestrus; the incidence of sterility was 10 and 80% at 60 and 120 days of age, respectively. When daily dose of 5β-DHT was reduced to 0.1 mg, however, only 33% of the rats resulted in sterility. These results suggest that the free form of T and non-aromatizable androgen, 5β-DHt, can permanently suppress the development of female type of neuroendocrine regulation. The possible participation of the process other than the central aromatization in androgenization will be discussed.

    AB - Wistar female rats were injected with testosterone (T) or 5β-dihydrotestosterone (5β-DHT) for the first 5 days of life. Neonatal treatment with 1 mg of T resulted in anovulatory persistent oestrous syndrome in 100% of the animals. In the females injected with 1 mg of 5β-DHT, 74% of the treated rats became sterile at 120 days of age. In addition, 0.5 mg 5β-DHT was also effective in inducing anovulatory persistent oestrus; the incidence of sterility was 10 and 80% at 60 and 120 days of age, respectively. When daily dose of 5β-DHT was reduced to 0.1 mg, however, only 33% of the rats resulted in sterility. These results suggest that the free form of T and non-aromatizable androgen, 5β-DHt, can permanently suppress the development of female type of neuroendocrine regulation. The possible participation of the process other than the central aromatization in androgenization will be discussed.

    UR - http://www.scopus.com/inward/record.url?scp=0019462817&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0019462817&partnerID=8YFLogxK

    M3 - Article

    VL - 96

    SP - 439

    EP - 443

    JO - European Journal of Endocrinology

    JF - European Journal of Endocrinology

    SN - 0804-4643

    IS - 4

    ER -